Private Advisor Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329K Sell
1,687
-1,764
-51% -$366K ﹤0.01% 2052
2026
Q1
$775K Sell
3,451
-234
-6% -$58.3K ﹤0.01% 1586
2025
Q4
$888K Buy
3,685
+28
+0.8% +$7.16K ﹤0.01% 1470
2025
Q3
$1M Buy
3,657
+98
+3% +$26.8K ﹤0.01% 1370
2025
Q2
$918K Buy
3,559
+315
+10% +$75.1K ﹤0.01% 1356
2025
Q1
$726K Buy
3,244
+501
+18% +$117K ﹤0.01% 1416
2024
Q4
$627K Sell
2,743
-103
-4% -$24.8K ﹤0.01% 1451
2024
Q3
$695K Sell
2,846
-225
-7% -$50.3K ﹤0.01% 1449
2024
Q2
$588K Buy
3,071
+402
+15% +$81.6K ﹤0.01% 1482
2024
Q1
$529K Buy
2,669
+46
+2% +$8.43K ﹤0.01% 1482
2023
Q4
$451K Buy
+2,623
New +$403K ﹤0.01% 1546
2023
Q3
Sell
-1,698
Closed -$376K 2362
2023
Q2
$376K Sell
1,698
-1
-0.1% -$223 ﹤0.01% 1504
2023
Q1
$372K Sell
1,699
-1,176
-41% -$255K ﹤0.01% 1452
2022
Q4
$296K Buy
2,875
+650
+29% +$143K 0.01% 755
2022
Q3
$486K Sell
2,225
-2,676
-55% -$609K 0.01% 1248
2022
Q2
$1.03M Buy
4,901
+361
+8% +$76.9K 0.01% 1058
2022
Q1
$1.1M Buy
4,540
+794
+21% +$192K 0.01% 1047
2021
Q4
$976K Sell
3,746
-2,055
-35% -$533K 0.01% 1128
2021
Q3
$1.53M Buy
5,801
+1,533
+36% +$419K 0.01% 1010
2021
Q2
$1.05M Sell
4,268
-199
-4% -$41.8K 0.01% 1038
2021
Q1
$866K Buy
4,467
+12
+0.3% +$2.41K 0.01% 1064
2020
Q4
$947K Buy
4,455
+212
+5% +$42.3K 0.01% 928
2020
Q3
$750K Sell
4,243
-136
-3% -$25.1K 0.01% 905
2020
Q2
$841K Buy
4,379
+1,179
+37% +$193K 0.01% 829
2020
Q1
$471K Sell
3,200
-196
-6% -$31.2K 0.01% 917
2019
Q4
$526K Sell
3,396
-33
-1% -$4.76K 0.01% 1024
2019
Q3
$463K Sell
3,429
-1,315
-28% -$172K 0.01% 1103
2019
Q2
$579K Sell
4,744
-142
-3% -$15.7K 0.01% 975
2019
Q1
$508K Sell
4,886
-2,125
-30% -$219K 0.01% 962
2018
Q4
$798K Buy
7,011
+265
+4% +$28.4K 0.02% 658
2018
Q3
$778K Buy
+6,746
New +$739K 0.02% 794
2017
Q2
Sell
-50,266
Closed -$73K 1457
2017
Q1
$73K Buy
+50,266
New +$3.47M ﹤0.01% 1375

Other funds holding RMD

Private Advisor Group's RMD Position: Q2 2026 in Review

Private Advisor Group reduced its ResMed (RMD) stake by 51% in Q2 2026, selling an estimated $366K and leaving 1,687 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #2052.

Private Advisor Group first reported a position in RMD in Q1 2017 and has held it in 32 quarters since. The position peaked at $1.53M in Q3 2021. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Private Advisor Group held 1,687 shares of ResMed worth $329K as of Q2 2026.
  • Private Advisor Group sold 1,764 ResMed shares in Q2 2026, an estimated $366K.
  • ResMed made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2052 holding.
  • Private Advisor Group first reported a position in ResMed in Q1 2017 and has held it in 32 quarters since.
  • Private Advisor Group's ResMed position peaked at $1.53M in Q3 2021.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.